Keyword: Remicade

News

Pfizer Sues J&J over Arthritis Drug

03.10.2017 - Pfizer is suing Johnson & Johnson (J&J) in the US over what it terms anti-competitive practices against its biosimilar Inflectra. The lawsuit is said to be the first of its kind...

News

UK Watchdog Accuses Merck of Breaking Competition Law

25.05.2017 - The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...

News

Italy Goes After Criminal Drug Reselling Ring

05.05.2014 - Italy is spearheading international efforts to catch a criminal ring that is stealing and recycling sophisticated drugs and reselling them for tens of millions of euros, the...

News

The Biosimilar Market

07.02.2014 - Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...

News

European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

01.07.2013 - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...

News

Merck Sees Fast Ruling in Johnson and Johnson's Remicade Arbitration

08.09.2010 - Merck said an arbitration panel would look in late September at whether the company is entitled to overseas rights to Remicade and Simponi, Johnson & Johnson's important rheumatoid...